This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • General Rhinology  • Neoplasms of Head & Neck  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

Continued Follow-up of a Single Institution's Experience

Andrew H. Loy, FRCS; James F. Reibel, MD; Paul W. Read, MD; Christopher Y. Thomas, MD; Steven A. Newman, MD; John A. Jane, MD; Paul A. Levine, MD

Arch Otolaryngol Head Neck Surg. 2006;132:134-138.

Objectives  To analyze outcomes and to provide follow-up for our increasing patient cohort with esthesioneuroblastoma.

Design  Retrospective cohort analysis.

Setting  Patients were examined from September 1, 1976, to May 30, 2004, in a tertiary care academic hospital.

Patients  Fifty consecutive patients diagnosed as having esthesioneuroblastoma were treated with a standardized protocol during a 28-year period. Patients with tumors staged Kadish A or B received preoperative radiotherapy followed by craniofacial resection, while patients with Kadish stage C disease were treated with preoperative sequential chemotherapy and radiotherapy followed by a craniofacial resection. The mean follow-up is 93 months (range, 1-330 months).

Results  The disease-free survival was 86.5% and 82.6% at 5 and 15 years, respectively. There were 17 patients (34%) who developed recurrent disease, most of which was locoregional (12 patients [71%]). There was a long interval to relapse (mean, 6 years), with the longest time to regional recurrence being 10 years. Distant relapses occurred sooner, with poorer outcomes. Of these 17 patients, 7 (41%) underwent successful salvage surgery, while 3 remain alive with disease.

Conclusions  Excellent outcomes for esthesioneuroblastoma are achievable. Long-term follow-up is necessary because of the extended interval for recurrent disease; unlike most sinonasal malignancies, surgical salvage is possible.

Author Affiliations: Departments of Otolaryngology–Head and Neck Surgery (Drs Loy, Reibel, and Levine), Radiation Oncology (Dr Read), Internal Medicine (Dr Thomas), Ophthalmology (Dr Newman), and Neurological Surgery (Dr Jane), University of Virginia Health System, Charlottesville. Dr Loy is now with the Department of Otorhinolaryngology, Tan Tock Seng Hospital, Singapore.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Salvage Treatment of Late Neck Metastasis in Esthesioneuroblastoma: A Meta-analysis
Gore and Zanation
Arch Otolaryngol Head Neck Surg 2009;135:1030-1034.
ABSTRACT | FULL TEXT  

Case 20-2007 -- An 11-Year-Old Boy with a Calcified Mass in the Nose
Cunningham et al.
NEJM 2007;356:2721-2730.
FULL TEXT  

Esthesioneuroblastoma: A Population-Based Analysis of Survival and Prognostic Factors
Jethanamest et al.
Arch Otolaryngol Head Neck Surg 2007;133:276-280.
ABSTRACT | FULL TEXT